Literature DB >> 8926104

V antigen-polyhistidine fusion peptide: binding to LcrH and active immunity against plague.

V L Motin1, Y A Nedialkov, R R Brubaker.   

Abstract

The structural gene for V antigen (lcrV) is known to be encoded within the lcrGVH-yopBD operon of the approximately 70-kb low-calcium-response or Lcr plasmid of Yersinia pestis. This 37-kDa monomeric peptide was reported to provide active immunity in mice, suppress inflammatory cytokines, and regulate expression of the low calcium response (Lcr+). Here we describe pVHB62, encoding a polyhistidine-V antigen fusion peptide (Vh) and linked LcrH. Vh underwent degradation from both the C terminus and N terminus during classical chromatographic fractionation but remained intact within two compartments during Ni2+ affinity chromatography. The first was homogeneous, capable of active immunization (mouse intravenous 50% lethal dose, > 10(7) bacteria), and stable at 4 degrees C. The second remained bound to the affinity column but could be eluted as a mixture of Vh, LcrH, and low-molecular-weight material by application of 6 M guanidine HCl. This mixture was dialyzed, denatured in 8 M urea, and again applied to the affinity column, which then hound Vh but not LcrH. The latter was recovered and renatured, and low-molecular-weight material was removed by biochemical fractionation. The resulting homogeneous LcrH bound protein AN antigen fusion peptide but not protein A in a sandwich enzyme-linked immunosorbent assay, and this reaction was inhibited by Vh. These observations indicate that LcrH normally binds V antigen in bacterial cytoplasm and suggest that only free LcrH down-regulates expression of the low calcium response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926104      PMCID: PMC174372          DOI: 10.1128/iai.64.10.4313-4318.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  VIRULENCE OF PASTEURELLA PESTIS AND IMMUNITY TO PLAGUE.

Authors:  T W BURROWS
Journal:  Ergeb Mikrobiol Immunitatsforsch Exp Ther       Date:  1963

2.  YscN, the putative energizer of the Yersinia Yop secretion machinery.

Authors:  S Woestyn; A Allaoui; P Wattiau; G R Cornelis
Journal:  J Bacteriol       Date:  1994-03       Impact factor: 3.490

3.  Physiological basis of the low calcium response in Yersinia pestis.

Authors:  J M Fowler; R R Brubaker
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

4.  Effect of exogenous nucleotides on Ca2+ dependence and V antigen synthesis in Yersinia pestis.

Authors:  R J Zahorchak; R R Brubaker
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

5.  In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae.

Authors:  T Une; R R Brubaker
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

6.  Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide.

Authors:  V L Motin; R Nakajima; G B Smirnov; R R Brubaker
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

7.  Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.

Authors:  R Nakajima; R R Brubaker
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  YopB and YopD constitute a novel class of Yersinia Yop proteins.

Authors:  S Håkansson; T Bergman; J C Vanooteghem; G Cornelis; H Wolf-Watz
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

9.  Proteolysis of V antigen from Yersinia pestis.

Authors:  R R Brubaker; A K Sample; D Z Yu; R J Zahorchak; P C Hu; J M Fowler
Journal:  Microb Pathog       Date:  1987-01       Impact factor: 3.738

10.  Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague.

Authors:  S E Leary; E D Williamson; K F Griffin; P Russell; S M Eley; R W Titball
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

View more
  20 in total

Review 1.  Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen).

Authors:  Robert R Brubaker
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.

Authors:  Kristin L DeBord; Deborah M Anderson; Melanie M Marketon; Katie A Overheim; R William DePaolo; Nancy A Ciletti; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  Amino acid and structural variability of Yersinia pestis LcrV protein.

Authors:  Andrey P Anisimov; Svetlana V Dentovskaya; Evgeniy A Panfertsev; Tat'yana E Svetoch; Pavel Kh Kopylov; Brent W Segelke; Adam Zemla; Maxim V Telepnev; Vladimir L Motin
Journal:  Infect Genet Evol       Date:  2009-10-14       Impact factor: 3.342

Review 4.  Type III protein secretion systems in bacterial pathogens of animals and plants.

Authors:  C J Hueck
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

5.  Failure to detect binding of LcrH to the V antigen of Yersinia pestis.

Authors:  K A Fields; A W Williams; S C Straley
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

6.  LcrV plague vaccine with altered immunomodulatory properties.

Authors:  Katie A Overheim; R William Depaolo; Kristin L Debord; Elizabeth M Morrin; Debra M Anderson; Nathaniel M Green; Robert R Brubaker; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  Development of in vitro correlate assays of immunity to infection with Yersinia pestis.

Authors:  J Bashaw; S Norris; S Weeks; S Trevino; J J Adamovicz; S Welkos
Journal:  Clin Vaccine Immunol       Date:  2007-03-21

8.  Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice.

Authors:  G E Benner; G P Andrews; W R Byrne; S D Strachan; A K Sample; D G Heath; A M Friedlander
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

9.  Amino acid residues 196-225 of LcrV represent a plague protective epitope.

Authors:  Lauriane E Quenee; Bryan J Berube; Joshua Segal; Derek Elli; Nancy A Ciletti; Deborah Anderson; Olaf Schneewind
Journal:  Vaccine       Date:  2009-12-10       Impact factor: 3.641

10.  Yersinia pestis caf1 variants and the limits of plague vaccine protection.

Authors:  Lauriane E Quenee; Claire A Cornelius; Nancy A Ciletti; Derek Elli; Olaf Schneewind
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.